Thermo Fisher Scientific Receivables

Thermo Fisher Scientific (TN8.DE) currently reports a receivables of $9.6B as of September 2026. That compares with $8.9B in the prior-year period — up 8.0% year over year. Use the charts on this page to explore Thermo Fisher Scientific's receivables history and peer comparisons.

Thermo Fisher Scientific's receivables increased from $8.9B to $9.6B — a 8.0% year-over-year increase (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Thermo Fisher Scientific reported $9.6B in receivables as of September 2026. That compares with $8.9B in the prior-year period — up 8.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $9.6B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Thermo Fisher Scientific, and consider following TN8.DE for alerts when major investors trade the stock.

Thermo Fisher Scientific is classified in the Healthcare sector. On receivables, it currently shows $9.6B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing TN8.DE with unrelated industries.